Pharmaceutical Executive Europe - February 2008 - (Page 11)

Pharmaceutical Executive Europe February 2008 R&D: Innovation 11 Learning to Share Novartis’s Paul Herrling tells Pharmaceutical Executive’s executive editor Joanna Breitstein that collaboration is key to faster, cheaper, and better R&D — and not only for neglected diseases. onprofit and for-profit R&D need to take a good look at one another. What one has, the other lacks. Scientists searching for drugs for neglected diseases typically work in open, collaborative systems and share information, but they lack the resources to invest heavily in large-scale clinical trials. On the other hand, when profits are at stake and competition is fierce, Big Pharma researchers very often plug in to their well-financed vacuum — even though the answers may not be found there. Scientists from the two worlds of research have a lot to learn from one another. But this time, nonprofit R&D execs are leading the charge. They are showing Big Pharma how to collaborate for the greater good, starting with drug safety, and in the process, rewriting the rules for research and development everywhere. Mindful of this, Novartis, with Paul Herrling at its helm, is fighting to make all areas of R&D more efficient by advocating collaboration and communication. With Novartis, Herrling helped start the SNP Consortium, the first major collaboration between prominent research institutions and pharma companies. Throughout his career, he has been able to bring together important R&D players. When Sandoz Pharmaceuticals merged with Ciba-Geigy to form Novartis in 1996, he led the companies’ integration and developed a new research model that had car engineers working side by side with biologists. When we caught up with Herrling — who, in addition to his day job at Novartis, is a professor at the University of Basel, Switzerland — he gave us a lesson in R&D. Herrling explained how the Novartis Institute for Tropical Diseases (NITD) is reaching out to other companies and utilising the newest technologies to research neglected diseases. Research institutions, pharmas, and agencies: pick up your pencils and start taking notes. N research in neglected diseases, and Novartis’s Singapore Institute is the most consistent. We’ve applied the most modern drug-discovery technology to find new drugs for diseases like TB and dengue. PE: What new techniques are you using in this area? PH: We only recently have the complete sequence of the genome of pathological organisms like TB and malaria. That means we can now apply all the tools of genomics to find characterised targets. Up until now, drugs for TB were found by throwing a compound at bug cultures to see which ones died, with no attention to targets or mechanism of action. The only questions were, Does it kill the bugs and does it have acceptable side effects? That’s much simpler than tweaking a subtle biological mechanism within the human body. It turns out, however, that TB is a highly sophisticated organism that has manoeuvred itself into a corner of evolution. Its speciality is to survive only in people, so it has evolved many mechanisms that allow it to do so. And one of the most perplexing and difficult — in terms of developing treatments — is that TB mycobacteria have learned, when they encounter negative conditions, to stop dividing and hide in the tissue. And they can stay there and then grow again after 50 years. Pharm Exec: Do you think neglected disease sets the standard in terms of efficiency? Or is it kind of behind the pack? Paul Herrling: If you are talking about neglected diseases in the developing world, like malaria and TB, then clearly we are on a major catch up. For example, the last tuberculosis drug that was put on the market was some 30 years ago. Of course, the reason nobody has worked in TB is that you can’t make any money — and drug companies are commercial organizations. We have to get a return on our research investment. Currently, there is only a handful of companies doing clinical

Table of Contents for the Digital Edition of Pharmaceutical Executive Europe - February 2008

Pharmaceutical Executive Europe - February 2008
Contents
From the Editor
News and Analysis
Brussels Report
Calendar
R&D: Innovation - Learning to Share
Drug Launch - The Preparation Game
Q&A - Getting a Head Start
Regulatory Compliance - Credible Compliance
Clinical Trials - Establishing Trials in China
The Mix - Relevant ROI
Comment - Taming the Trader
Last Word - Under the Microscope

Pharmaceutical Executive Europe - February 2008

http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201302
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201301
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201212
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201211
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201210
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201209
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201208
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201207
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201206
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201205
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201204
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201203
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201202
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201201
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201112
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201111
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201110
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_201109
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110823
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110809
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110728_v2
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110728
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110711
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110624
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110609
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110526
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110512
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_oracle_201105
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110426
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110412
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110324
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110310
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110224
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110208
http://digital.findpharma.com/nxtbooks/advanstaruk/pegd_20110128
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_mediakit2011
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101216
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101124
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101111
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101027
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20101013
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100930
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100915_supp
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100915
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100825
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100811
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100727
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100713
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100623
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100609
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100526
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100512
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_ims_201005
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100427
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100414
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100324
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100310
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100224
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100210
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100126
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20100112
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091222
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091208
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091124
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091110
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091027
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091013
http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_DIGEST_20090930
http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_digest_20090916
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090902
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090825
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090819
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090812
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090805
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090729
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090721
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090715
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090708
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090701
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090624
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090617
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090610
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090602
http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090526
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090519
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090512
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090505
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_southafrica
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090429
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090422
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090415
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090408
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401_v2
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090325
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090318
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090311
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090304
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090224
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090218
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090211
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090203
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090128
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090121
https://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090114
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1208
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1108
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1008
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1008
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0908
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0808
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0708
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0608
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0508
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0508
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0408
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0308
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0208
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0208
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0108
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1207
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1107
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1007
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imsoncology0907
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0407
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0307
https://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1206
https://www.nxtbookmedia.com